SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
The Full Value of Vaccine Assessments (FVVA): a framework for assessing and communicating the value of vaccines for investment and introduction decision-making
16 references·0 citing·48 second hop
The Full Value of Vaccine Assessments (FVVA): a framework for assessing and communicating the value of vaccines for investment and introduction decision-making (2023)The Full Value of Vaccine Assessments (FV…The Economic Case for Global Vaccinations: An Epidemiological Model with International Production Networks (2021)The Economic Case for Global …Methods for the Economic Evaluation of Health Care Interventions for Priority Setting in the Health System: An Update From WHO CHOICE (2021)Methods for the Economic Eval…International Collaboration to Ensure Equitable Access to Vaccines for COVID‐19: The ACT‐Accelerator and the COVAX Facility (2021)International Collaboration t…Immunization: vital progress, unfinished agenda (2019)Immunization: vital progress,…The International Decision Support Initiative Reference Case for Economic Evaluation: An Aid to Thought (2016)The International Decision Su…Multiple Criteria Decision Analysis for Health Care Decision Making—An Introduction: Report 1 of the ISPOR MCDA Emerging Good Practices Task Force (2016)Multiple Criteria Decision An…Extended Cost-Effectiveness Analysis for Health Policy Assessment: A Tutorial (2016)Extended Cost-Effectiveness A…The broader economic impact of vaccination: reviewing and appraising the strength of evidence (2015)The broader economic impact o…Budget Impact Analysis—Principles of Good Practice: Report of the ISPOR 2012 Budget Impact Analysis Good Practice II Task Force (2013)Budget Impact Analysis—Princi…Systematic review of studies evaluating the broader economic impact of vaccination in low and middle income countries (2012)Systematic review of studies …Dynamic Transmission Modeling (2012)Dynamic Transmission ModelingCost-effectiveness and economic benefits of vaccines in low- and middle-income countries: A systematic review (2012)Cost-effectiveness and econom…Rethinking the benefits and costs of childhood vaccination: The example of the Haemophilus influenzae type b vaccine☆ (2010)Rethinking the benefits and c…Principles of Good Practice for Budget Impact Analysis: Report of the ISPOR Task Force on Good Research Practices—Budget Impact Analysis (2007)Principles of Good Practice f…Deliberative processes and evidence-informed decision making in healthcare: do they work and how might we know? (2006)Deliberative processes and ev…Generalized cost-effectiveness analysis for national-level priority-setting in the health sector (2003)Generalized cost-effectivenes…Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement (2009)Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement (2009)Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement. (2009)Valuing vaccination (2014)Estimated economic impact of vaccinations in 73 low- and middle-income countries, 2001–2020 (2017)Consolidated Health Economic Evaluation Reporting Standards (CHEERS)—Explanation and Elaboration: A Report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force (2013)Essential medicines for universal health coverage (2016)Consolidated Health Economic Evaluation Reporting Standards (CHEERS) 2022 Explanation and Elaboration: A Report of the ISPOR CHEERS II Good Practices Task Force (2022)Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) Statement: Updated Reporting Guidance for Health Economic Evaluations (2022)Principles of Good Practice for Decision Analytic Modeling in Health-Care Evaluation: Report of the ISPOR Task Force on Good Research Practices—Modeling Studies (2003)Current Status and Future Prospects of Clinical Psychology (2008)Propuesta de guía para la evaluación económica aplicada a las tecnologías sanitarias (2009)Mental disorders and medical comorbidity. (2011)Five‐Hundred Life‐Saving Interventions and Their Cost‐Effectiveness (1995)A framework for assessing the performance of health systems. (2000)Making choices in health: who guide to cost-effectiveness analysis (2004)Cost-Effectiveness Thresholds: the Past, the Present and the Future (2018)Use and Misuse of Cost-Effectiveness Analysis Thresholds in Low- and Middle-Income Countries: Trends in Cost-per-DALY Studies (2018)Eliciting and Utilizing Willingness to Pay: Evidence from Field Trials in Northern Ghana (2019)A scaling method for priorities in hierarchical structures (1977)Decisions with Multiple Objectives: Preferences and Value Tradeoffs. (1994)Multiple Criteria Decision Analysis: State of the Art Surveys (2005)Multiple Criteria Decision Analysis for Health Care Decision Making—Emerging Good Practices: Report 2 of the ISPOR MCDA Emerging Good Practices Task Force (2016)A bibliometric-based survey on AHP and TOPSIS techniques (2017)The Lancet Psychiatry Commission on youth mental health (2024)Cost-Effectiveness in Health and Medicine (1996)Methods for the Economic Evaluation of Health Care Programmes (2005)World Development indicators (2015)Economic Analysis of Vaccination Programs: An ISPOR Good Practices for Outcomes Research Task Force Report (2018)Identifying the Need for Good Practices in Health Technology Assessment: Summary of the ISPOR HTA Council Working Group Report on Good Practices in HTA (2018)An Introduction to the Main Types of Economic Evaluations Used for Informing Priority Setting and Resource Allocation in Healthcare: Key Features, Uses, and Limitations (2021)Alternative projections of mortality and disability by cause 1990–2020: Global Burden of Disease Study (1997)On discount rates for economic evaluations in global health (2019)A Health Opportunity Cost Threshold for Cost-Effectiveness Analysis in the United States (2020)Perspective and Costing in Cost-Effectiveness Analysis, 1974–2018 (2020)Simply put: Vaccination saves lives (2017)Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017 (2018)Vaccine hesitancy around the globe: Analysis of three years of WHO/UNICEF Joint Reporting Form data-2015–2017 (2018)Improving vaccination uptake among adolescents (2020)Mapping routine measles vaccination in low- and middle-income countries (2020)The Changing Acceptance of COVID-19 Vaccination in Different Epidemic Phases in China: A Longitudinal Study (2021)World Population Prospects The 2006 Revision (2007)Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010 (2012)Introduction to the Special Issue on "The World Health Organization Choosing Interventions That Are Cost-Effective (WHO-CHOICE) Update" (2021)An overview of the perspectives used in health economic evaluations (2024)COVAX and the rise of the ‘super public private partnership’ for global health (2021)COVID-19 Vaccination in Lower-Middle Income Countries: National Stakeholder Views on Challenges, Barriers, and Potential Solutions (2021)Global COVID-19 vaccine inequity: The scope, the impact, and the challenges (2021)
this work references cited by second hop

References

  • 2013Budget Impact Analysis—Principles of Good Practice: Report of the ISPOR 2012 Budget Impact Analysis Good Practice II Task Force1,177 cited
  • 2007Principles of Good Practice for Budget Impact Analysis: Report of the ISPOR Task Force on Good Research Practices—Budget Impact Analysis751 cited
  • 2016Multiple Criteria Decision Analysis for Health Care Decision Making—An Introduction: Report 1 of the ISPOR MCDA Emerging Good Practices Task Force738 cited
  • 2003Generalized cost-effectiveness analysis for national-level priority-setting in the health sector535 cited
  • 2016The International Decision Support Initiative Reference Case for Economic Evaluation: An Aid to Thought328 cited
  • 2012Cost-effectiveness and economic benefits of vaccines in low- and middle-income countries: A systematic review254 cited
  • 2016Extended Cost-Effectiveness Analysis for Health Policy Assessment: A Tutorial251 cited
  • 2021International Collaboration to Ensure Equitable Access to Vaccines for COVID‐19: The ACT‐Accelerator and the COVAX Facility210 cited
  • 2019Immunization: vital progress, unfinished agenda206 cited
  • 2021Methods for the Economic Evaluation of Health Care Interventions for Priority Setting in the Health System: An Update From WHO CHOICE160 cited
  • 2015The broader economic impact of vaccination: reviewing and appraising the strength of evidence152 cited
  • 2012Dynamic Transmission Modeling151 cited
  • 2006Deliberative processes and evidence-informed decision making in healthcare: do they work and how might we know?

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

137 cited
  • 2010Rethinking the benefits and costs of childhood vaccination: The example of the Haemophilus influenzae type b vaccine☆129 cited
  • 2012Systematic review of studies evaluating the broader economic impact of vaccination in low and middle income countries128 cited
  • 2021The Economic Case for Global Vaccinations: An Epidemiological Model with International Production Networks124 cited
  • Cited by

    No citing works inside the corpus for this window.